Back to Search
JESSICA SHAND, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1265449581Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
268270(NY)
Research & Publications (20)
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches.
PMID 19139888·Cancer Immunol Immunother·2009
7-preclinical
IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response.
PMID 19614612·Biochem Soc Trans·2009
6-review
The influence of ontogeny and light environment on the expression of visual pigment opsins in the retina of the black bream, Acanthopagrus butcheri.
PMID 18424684·J Exp Biol·2008
4-observational
Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study.
PMID 17899320·Mol Cell Biochem·2008
6-review
An unusual cause of locking after total knee replacement.
PMID 17905968·J Bone Joint Surg Br·2007
5-case
Postoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits.
PMID 17414283·J Craniofac Surg·2007
7-preclinical
Isolation and characterization of melanopsin (Opn4) from the Australian marsupial Sminthopsis crassicaudata (fat-tailed dunnart).
PMID 17785267·Proc Biol Sci·2007
7-preclinical
Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
PMID 16195401·Endocrinology·2006
7-preclinical
Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
PMID 16505491·J Biol Chem·2006
7-preclinical
Adolescents and young adults successfully restore lymphocyte homeostasis after intensive T-cell depleting therapy for cancer.
PMID 17010050·Br J Haematol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE
ROCHESTER, NY 14642 - Phone
- (585) 275-2981
Quick Facts
- NPI
- 1265449581
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile